期刊文献+

两种剂量达必佳在体外受精-胚胎移植中治疗效果的比较 被引量:11

Comparison of Decapeptyl of two different dosage in assisting IVF-ET
下载PDF
导出
摘要 目的:探讨在体外受精- 胚胎移植(IVF-ET)中达必佳的最适剂量。方法: 将接受IVF-ET助孕,采用长方案的患者84例随机分为观察组和对照组,观察组44例,每日皮下注射达必佳1/3支(0.03 mg),对照组40 例,每日皮下注射达必佳1 支(0.1 mg),比较其治疗效果。结果: 观察组促性腺激素(Gn)用量明显少于对照组 (27.5±4.5支vs 36.6±7.5支,P <0.05);Gn用药时间少于对照组(9.10±2.52 d vs 11.67±3.31 d),但无统计学意义;使用Gn前及hCG注射日血LH水平明显高于对照组(3.89±0.41 IU/L vs 1.25±0.32 IU/L,P <0.001;3.27±0.98IU/L vs 1.01±0.21 IU/L, P <0.001),而使用Gn前血E2水平、hCG注射日的血P、E2水平、获卵数、受精率、优质胚胎率、妊娠率两组间均无显著性差异。两组均无内源性LH峰出现。结论:1/3剂量达必佳即可达到降调节的作用,且能减少Gn的用量,获得与标准剂量达必佳相同的临床效果。
出处 《生殖与避孕》 CAS CSCD 北大核心 2005年第1期53-55,共3页 Reproduction and Contraception
  • 相关文献

参考文献11

  • 1赵晓明,陈珠萍,林其德.标准剂量和半量缓释型达必佳在体外受精-胚胎移植中治疗效果的比较[J].生殖与避孕,2002,22(4):243-246. 被引量:20
  • 2任海芹,李伟,孙淑杰,孙晓玲,赵广凤,翁宁,许薇.不同剂量长效达必佳在体外受精-胚胎移植中的治疗效果观察[J].中国实用妇科与产科杂志,2004,20(1):57-58. 被引量:14
  • 3Porter RN, Smith W, Graft IL, et al. Induction of ovulation for in-vitro fertilization using buserelin and gonadolrophins.Lancet, 1984, 2(8 414):1 284-5.
  • 4Dale B & Elder K. In vitro fertilization. Cambridge: Cambridge University Press, 1997, p.115-6.
  • 5Beloosesky R, Kol S, Lightman A. et aL Ovarian stimulation in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycleduration and outcome. Fertil Steril, 2000, 74(1): 166-8.
  • 6Ben-Rafael Z,Lipitzs S,Blacr D,et al,Ovarian hyporesponsiveness in combined gonadotropin releasing hormone agonist and menotropin therapy is associated with low serum follicle stimulating hormone levels. Fertil Steril,1991, 55(2):272-5.
  • 7Felberg D, Dicker D, Farhi J, et al. Minidose gonadotropinreleasing hormone agonist is the treatment of choice in poor responders with high follicle stimulating hormone levels.Fertil Steril, 1994, 64(2):343-6.
  • 8Taskin O, Gokdeniz R, Atmaca R, et al. Normal pregnancy outcome after inadvertent exposure to long-acting gonadotropin-releasing hormone agonist in early pregnancy. Hum Reprod, 999, 14(7):1 368-71.
  • 9Ron-El R, Herman A, Golun A, et al. Gonadotropins and combined gonadotropin-releasing hormone agonist/gonadotropins protocols in a randomized prospective study. Fertil Steril, 1991, SS(3):574-8.
  • 10Ron-El R, Herman A, Golan A, et al. Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone. Fertil Steril, 1992, 58(6):1 164-8,.

二级参考文献13

  • 1Bstandig B, Cedrin-Durnerin I & Hugues JN. Effec tiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare up. J Assisted Reprod Genetics, 2000,17 : 1 13 ~ 117.
  • 2Raphael RonelL, Eliahu Caspi, Abraham Golan, et al. A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patiens. Iht J Fertil, 1991,36:157~161.
  • 3Balasch J, Gomez F, Carmona R, et al. Pituitary -ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot. Human Reprod, 1992,7:1 230~1 234.
  • 4Simon A,Benshushan A, Shusan A, et al. A compari son between a standard and reduced dose of D-Trp-6luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization. Human Reprod, 1994, 9; 1 813~1 817.
  • 5Peter R & Brinsden R. The Bourn Hall Quide to Clini cal and Laboratory Practice, In vitro Fertilization and Assisted Reproduction. New York: The Parthenon Publishing Group Ltd, 1999 ,p. 91~ 102
  • 6ZHUANG Guang-lun & ZHOU Can-quan. In vitro fertilization and transfer embryo. In: LUO Li-lan. ed. Infertility and Infecundity (in Chinese). Beijing: People's Medical Publication House, 1998, p. 415.
  • 7Happ J, Schuhheiss H, Jacobi GH,et al. Phaemacodynamics, Pharmacokinetics and bioavailability of prolonged LH-RH agonist-SR. In JGM Klijin. ed. Hormonal Manipulation of Cancermograph Series of the European Organization for Research on Treatment for Cacer, Vol 18, New York: Raven Press, 1987, p. 249
  • 8Dor J, Bider D, Shulman A, et al. Effects of go nadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective, randomizd in-vitro fertilization study. Human Reprod, 2000, 15:1 225~1 230.
  • 9Miro F, Sampaio MC, Tarin JJ, et al. Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with two gonadotropin releasing hormone analogs employing different protocols. Gynecol Endocrinol, 1992,6 : 77~84.
  • 10Smitz JEI, Ron R & Tarlatzis BC. The use of go nadotrophin releasing hormone agonists for in-vitro fertilization and other assisted procreation techniques: experience from three centers. Hum Reprod, 1992, 7 (Suppl. 1): 49~46.

共引文献27

同被引文献127

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部